论文部分内容阅读
目的研究双水平正压通气(Bi PAP)无创通气治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭临床应用价值。方法 60例COPD合并Ⅱ型呼吸衰竭患者为研究对象,将其随机分为观察组与对照组,各30例。两组患者均给予常规方法治疗,观察组在常规治疗基础上联合应用Bi PAP无创通气治疗,比较来两组患者的临床疗效。结果观察组患者的呼吸频率、血气分析指标[酸碱度(p H)、动脉血氧分压(Pa O2)、动脉血二氧化碳分压(Pa CO2)]均优于对照组,差异有统计学意义(P<0.05)。结论 Bi PAP无创通气治疗COPD合并Ⅱ型呼吸衰竭的临床疗效显著,值得在临床上推广。
Objective To study the clinical value of Bi PAP noninvasive ventilation in the treatment of chronic obstructive pulmonary disease (COPD) complicated with type Ⅱ respiratory failure. Methods Sixty patients with COPD and type Ⅱ respiratory failure were randomly divided into observation group and control group, with 30 cases in each group. The two groups of patients were given conventional treatment, the observation group on the basis of conventional therapy combined with Bi PAP non-invasive ventilation, compared to the clinical efficacy of both groups of patients. Results The respiratory rate, blood gas analysis index (pH, Pa O2, Pa CO2) of the observation group were better than those of the control group (P < P <0.05). Conclusion Bi PAP has significant clinical efficacy in treating COPD with type Ⅱ respiratory failure and is worthy of clinical application.